We have previously reported that a novel polysaccharide, MPSSS, from Lentinus edodes can reverse the function of myeloid immune suppressor cell-mediated T cell inhibition and improve the efficacy of 
Introduction
Polysaccharides isolated from Lentinus edodes have been widely studied and show potential anti-tumor activity.
1 A b-1,3-glucan extracted from L. edodes has been used as an adjuvant drug for immune-modulators in the treatment of cancer.
2, 3 Our previous study found that a novel polysaccharide, MPSSS, from L. edodes can reduce the immunological suppression of myeloid-derived suppressor cells (MDSCs) in tumors, and its polymer fraction mainly consists of a b-1,6-linked glucan branched at C-4 with side chains, which are also b-1,6-linked glucans. 4 In tumor-bearing mice, MDSCs are generated in the bone marrow and migrate to the peripheral lymphoid organs and tumor tissues. 5 The major function of the MDSCs during tumor progression is to inhibit T cell activity and promote tumor growth. [6] [7] [8] [9] To further investigate the nature and properties of these cells, myeloid suppressor cells were immortalized using a retrovirus encoding the v-myc and v-raf oncogenes. The MSC2 immortalized cells expressed monocyte/macrophage markers and still had the capacity to inhibit T lymphocyte activation.
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In this study, MSC2 cells were used to determine the underlying mechanism of the reduction of MDSC-mediated T cell inhibition by MPSSS. Here, we found that MPSSS signi-cantly suppressed the arginase activity and TNFR2 of the MSC2 cells, which were necessary for MDSC survival and inhibited T cell proliferation. Moreover, MPSSS impaired the immunosuppressive function of the MSC2 cells through p38 activation. These results showed that MPSSS treatment caused the MSC2 cells to differentiate into M1-type macrophages, which are regarded as tumor-inhibiting. 11 Thus, our work demonstrates that MPSSS regulates the p38 activation of MSC2 cells and promotes these cells to differentiate into M1-type macrophages and then reduces the immune suppression of the MSC2 cells. These results indicate that MPSSS is a potential candidate for an anti-tumor treatment that targets MDSCs.
Materials and methods

Chemicals and reagents
Carboxyuoresceinsuccinimidyl ester (CFSE), L-arginine and aisonitrosopropiophenone were purchased from Sigma-Aldrich (Darmstadt, Germany). The p38 inhibitor SB203580 and RIPA lysis buffer were purchased from Beyotime Biotechnology (Suzhou, China). DMEM and RPMI-1640 medium were purchased from HyClone (Logan, Utah, USA). Fetal bovine serum (FBS) was purchased from PAN (Aidenbach, Germany). Penicillin/ streptomycin and TRIzol reagent were purchased from Invitrogen (Carlsbad, CA, USA). PrimeScript RT Master Mix and SYBR Green II Mix were purchased from Takara (Kusatsu, Shiga, Japan). TNFa and TGF-b1 ELISA kits were purchased from eBioscience (San Diego, CA, USA). PVDF membranes were purchased from Millipore (Darmstadt, Germany). The primary antibodies Phospho(P)-p38, p38, p-ERK, ERK, p-STAT1 and STAT1 were purchased from Cell Signaling Technology (Massachusetts, USA). GAPDH was purchased from Sanjian (Tianjin, China). Secondary anti-mouse and anti-rabbit antibodies were obtained from ZSGBbio (Beijing, China). Antibodies including APC-anti-CD4, PE-antiCD8a, PE-anti-TNFR1 and PE-anti-TNFR2 were purchased from Biolegend (Cambridge, UK). All other chemicals and reagents used in this study were of analytical grade.
Cell culture
MSC2 cells were maintained in DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37 C in an incubator with a humidied atmosphere of 5% CO 2 .
T cell proliferation assay
T cell proliferation was measured using the intracellular dye carboxyuoresceinsuccinimidyl ester (CFSE). Splenocytes were isolated from Balb/c mice and incubated in RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin/ streptomycin at 37 C in an incubator with a humidied atmosphere of 5% CO 2 for 4 hours. Suspension cells were then collected and labelled with 1 mM CFSE at 25 C for 2 minutes, followed by quenching in 10% FBS-RPMI 1640 medium. CFSElabeled splenocytes were co-cultured at a 100 : 3 ratio with MSC2 cells, stimulated with 1 mg ml À1 ConA, and sorted by the FACS Aria III (BD Biosciences San Diego, CA, USA). Aer 3 or 5 days, the cells were stained with APC-anti-CD4 and PE-antiCD8a, and the CFSE signal of the gated lymphocytes was analyzed. Animal experiments were carried out in accordance with the Guidelines for the Care and Use of Laboratory Animals of the National Institute of Health, and were approved by the Biological Research Ethics Committee, Institute of Biophysics, Chinese Academy of Sciences.
Arginase activity
Arginase activity was determined by measuring the amount of urea generated from the hydrolysis of L-arginine, as previously described. 12 Briey, 10 6 MSC2 cells were solubilized with 100 ml lysis solution (0.1% Triton X-100, 10 mM MnCl 2 , and 25 mM
Tris-HCl). The lysate was activated at 56 C for 10 min, supplemented with 200 ml 500 mM L-arginine (pH 9.7) and then incubated at 37 C for 60 min. The reaction was stopped by 800 ml H 2 SO 4 /H 3 PO 4 /H 2 O (1 : 3 : 7 v/v/v). Subsequently, 40 ml a-isonitrosopropiophenone (dissolved in ethanol) was added, followed by another heating at 100 C for 30 min. The absorbance of the concentration of urea was measured at 540 nm. One unit of enzyme activity was dened as the amount of enzyme that catalyzed the formation of 1 mmol of urea per minute.
Flow cytometry
Cells were labelled for immunouorescence and analyzed by ow cytometry for cell surface molecules. Antibodies including APC-anti-CD4, PE-anti-CD8a, PE-anti-TNFR1 and PE-anti-TNFR2 were diluted in PBS with 2% FBS.
Protein extraction and immunoblotting assay
MPSSS-treated MSC2 cells were collected and lysed by a RIPA solution supplemented with 100 mM phenylmethanesulfonyl uoride, 25 mg ml À1 aprotinin, 1 mM sodium orthovanadate and 50 mM NaF. The total protein concentrations were determined by the BCA protein assay. An equal amount of proteins was resolved on a 10% SDS-PAGE gel and then transferred to PVDF membranes. The primary antibodies used were: Phospho(P)-p38, p38, p-ERK, ERK, p-STAT1 and STAT1, which were diluted at 1 : 1000, and GAPDH was diluted at 1 : 8000. HRP-conjugated goat anti-mouse or goat anti-rabbit IgG were used as secondary antibodies. ImageJ soware was used to quantify the band density.
RNA extraction and real-time PCR
Total RNA was extracted from the MSC2 cells using TRIzol reagent and quantied on an ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Total RNA was reverse transcribed with the PrimeScript RT Master Mix. The amounts of TNFa, TGF-b1, NOS2, HO1 and c/EBPb mRNA were determined using the SYBR Green II Mix on an Applied Biosystems 7500. The internal control used was 18S rRNA. The primers sequences were listed in ESI Table S1 . †
Cytokine detection
TNFa and TGF-b1 in the culture supernatants were detected with ELISA kits.
Statistical analysis
Quantitative data are presented as the mean AE standard deviation (SD) from three or more independent experiments. Student's t test was used to assess the differences between two groups, and P < 0.05 was considered statistically signicant.
Results
MPSSS can impair the immunosuppressive function of MSC2 cells
MSC2 cells were treated with or without MPSSS or lentinan. Aer 24 hours, the pretreated MSC2 cells were co-cultured with a suspension of splenocytes from Balb/c mice, labelled with CFSE, and stimulated with 1 mg ml À1 ConA. As shown in Fig. 1A , the CD4 + (Fig. 1B) or CD8 + (Fig. 1C) T cell proliferation upon
ConA stimulation was drastically inhibited by the MSC2 cells. However, when the MSC2 cells were treated with MPSSS, the immunosuppressive activity of the MSC2 cells was impaired.
Lentinan had no similar effect on MSC2 cells (ESI Fig. S1 †) . MPSSS had no effect on T cells and T cells proliferation induced by ConA (ESI Fig. S2 †) . Compared with the absence of MPSSS treatment, the activities of arginase in the MSC2 cells treated with MPSSS were downregulated (Fig. 1D) . In addition, the cellmembrane receptor TNFR2 was decreased aer MPSSS treatment (Fig. 1E ), but TNFR1 was unaffected by the MPSSS treatment (Fig. 1F) .
MPSSS promoted MSC2 cell differentiation into M1-type cells
To investigate the effect of MPSSS on the differentiation of the MSC2 cells, the mRNA levels of NOS2, TNFa and TGF-b1 were analyzed by real-time PCR. Aer MPSSS treatment of the MSC2 cells over different time periods, the mRNA levels of NOS2 ( Fig. 2A) and TNFa (Fig. 2B) were increased, and the maximum mRNA level of TNFa was 30 fold higher than that of untreated cells (Fig. 2B) . In contrast to TNFa, the mRNA level of TGF-b1 was down regulated in the presence of MPSSS treatment compared to that in the absence of MPSSS treatment (Fig. 2C) . Together, the results showing the downregulation of arginase and upregulation of NOS2 ( Fig. 2A) indicated that MPSSS promoted the differentiation of the MSC2 cells into M1-type cells.
MPSSS activated the p38 MAPK pathway
To investigate the effects of MPSSS on the activation of MAPKs, the MSC2 cells were treated with 100 mg ml À1 MPSSS for different time periods up to 8 hours. Western blot results showed that p38 was activated (phosphorylated) at maximum levels 0.5-2 h aer MPSSS treatment ( Fig. 3A and C) . In addition, the levels of phosphorylated ERK were decreased aer MPSSS treatment ( Fig. 3B and D) . As shown in Fig. 3A , the transcription factor STAT-1 was activated, which is an essential step for NOS2 induction in most cells.
MPSSS impairs the inhibitory function of MSC2 cells though the p38 pathway
To investigate the role of p38 in the T cell proliferation and induction of arginase following MPSSS treatment, the MSC2 cells were pretreated with a p38 inhibitor SB203580 at 1 hour before MPSSS treatment. The results showed that MPSSS impaired the immunosuppressive function of the MSC2 cells, which was eliminated aer the SB203580 pretreatment ( Fig. 4A-C) . In addition, when the p38 pathways were blocked, the activities of arginase in the MSC2 cells treated with MPSSS rapidly increased (Fig. 4D ). In the presence of the SB203580 treatment, TNFR2 in the MPSSS-treated MSC2 cells was upregulated compared to that in the absence of the SB203580 treatment (Fig. 4E) . With the same treatment, TNFR1 in the MSC2 cells was unaffected (Fig. 4F) .
Inhibition of p38 blocked the differentiation of the MSC2 cells and recovered the expression of c/EBPb and HO1 induced by MPSSS
To investigate the effect of p38 on the differentiation of MSC2, we evaluated the effect of MPSSS on the MSC2 cells, which were pretreated with or without SB203580. The pretreated MSC2 cells were stimulated with MPSSS 24 hours. Then, the supernatant was used to detect TNFa and TGF-b1 by ELISA. Interestingly, the expression of TNFa was increased signi-cantly aer MPSSS treatment compared to that of the untreated cells or the SB203580 pretreatment cells (Fig. 5A) . Meanwhile, the expression of TGF-b1 was reduced aer MPSSS stimulation (Fig. 5B) . The transcriptional factor c/EBPb can activate the arginase promoter. We therefore assayed the mRNA level of c/EBPb. The expression levels of c/EBPb was decreased under simulation with MPSSS compared with those of the untreated MSC2 cells or The relative mRNA expression levels of (A) NOS2, (B) TNFa and (C) TGFb1 were assayed by qPCR after 100 mg ml À1 MPSSS treatment in a time-dependent manner. *p < 0.05, **p < 0.01, and ***p < 0.001 versus 0 h group. the MPSSS plus SB203580-treated MSC2 cells (Fig. 5C ). Depletion of arginine by arginase plays a major role in the MDSCmediated T cell inhibition. In addition, the MPSSS-treated MSC2 cells can downregulate the expression of HO-1, and the SB203580 pretreatment of the MSC2 cells reversed this phenomenon (Fig. 5D) . 
Discussion
Our previous study isolated a polysaccharide, MPSSS, with a molecular weight of 5.772 Â 10 5 daltons (Da) from L. edodes.
Analysis of the monosaccharide composition of MPSSS showed that this polysaccharide fraction was mainly composed of glucose (75.0%), galactose (11.7%) and mannose (7.8%). The anti-cancer effect of MPSSS has been demonstrated; MPSSS reduced MDSC numbers and eliminated the MDSC-mediated T cell inhibition.
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MDSCs aid tumor development by providing molecules and factors essential for angiogenesis and tumor metastasis and exert a profound inhibitory effect on T lymphocytes. 13 Depletion of arginine by arginase plays a major role in the MDSCmediated T cell inhibition.
14 Furthermore, we have previously demonstrated that TNFR2 signaling promotes MDSC survival and accumulation and helps tumor cells evade the immune system. 15, 16 It has been reported that transmembrane TNFa but not secretory TNFa can activate MDSCs with enhanced suppressive activities via TNFR2 and promote tumor progression. 16 In the present study, the results showed that MPSSS inhibited the suppressive function of the MSC2 cells, with signicantly downregulated arginase activity (Fig. 1D ) and decreased TNFR2 (Fig. 1E ) but did not affect TNFR1 (Fig. 1F) and impaired the inhibition of T cell proliferation (Fig. 1A-C) .
Induction of arginase and NOS2 is critical for macrophage polarization and function. 17 Classical activation of macrophages by IFN-g induces M1 polarization and results in the upregulation of TNF-a and induction of NOS2. 18 On the other hand, the alternative activation of macrophages by Th2 cytokines induces M2 polarization and results in the upregulation of TGFb and arginase. 11, 19, 20 In all cases, the M1 phenotype cells are regarded as tumor-inhibiting, and the M2 phenotype cells are considered tumor-promoting. 11 Our study demonstrated that MPSSS promoted MSC2 differentiation into M1-type cells, including elevated mRNA levels of NOS2 ( Fig. 2A) and TNFa (Fig. 2B) , with signicantly decreased TGFb1 mRNA (Fig. 2C) . ERK activation is needed for arginase induction in activated macrophages and the M2 phenotype, while NOS2 induction depends on p38 activation. 17 Mitogen and stress activated kinases 1 and 2 are activated by the p38 pathway and activate the transcription factor STAT1. 21, 22 Activation of the transcription factor STAT1 and the activation of the NOS2 promoter seem to be an essential step for NOS2 induction in most cells. 23 Here, we found that p38 and STAT-1 were activated aer MPSSS treatment in the MSC2 cells (Fig. 3A) . Additionally, activation of ERK was clearly downregulated (Fig. 3B) .
Hence, we wondered whether p38 activation plays a crucial role in the MPSSS-eliminated MSC2-mediated T cell inhibition. SB203580 is a p38 inhibitor that was identied to bind competitively at the ATP-binding pocket and has been widely used to study p38 functions. [24] [25] [26] [27] In this study, we found that MPSSS induced an $4-fold increase in the secretion of TNFa, which was blocked by SB203580 (Fig. 5A) . As expected, inhibition of p38 completely reversed the effects of the MPSSS treatment and effectively decreased TGFb1 secretion (Fig. 5B) , arginase activity (Fig. 4D ) and the expression of TNFR2 (Fig. 4E) . Furthermore, MPSSS-stimulated MSC2 cells, which were pretreated with SB203580, could not prevent the inhibition of T cell proliferation (Fig. 4A-C) .
It has been reported that c/EBPb appears to play a major role in the induction of arginase expression, 28 which acts downstream of ERK. 29 Here, we found that MPSSS inhibited the expression of c/EBPb (Fig. 5C ) and reduced p-ERK (Fig. 3B) . Interestingly, blocking the p-38 pathway showed that the expression of c/EBPb and activation of arginase (Fig. 4D) were unaffected aer MPSSS treatment. Some studies have shown that p38 MAPK signaling causes rapid inactivation of the ERK pathway mediated by PP2A. 21, 30 In addition, direct interaction between ERK and p38 MAPKs might also inhibit ERK phosphorylation. 30 A previous study revealed that heme oxygenase-1 (HO-1) is one of the key mediators of the MDSC-associated suppression mechanism in transplantation, 31 which leads to inhibition of T-cell proliferation through carbon monoxide (CO) production. 32 In this study, we found that MPSSS-treated MSC2 cells could downregulate the expression of HO-1, and SB203580 pretreatment of the MSC2 cells reversed the phenomenon (Fig. 5D ).
Conclusions
In conclusion, we found that a novel polysaccharide, MPSSS, obtained from L. edodes induced the differentiation of MSC2 cells and impaired their immunosuppressive function by suppressing arginase activity and the expression of TNFR2 via activation of p38 and dephosphorylation of ERK. The possible mechanisms involved in this process are illustrated in Fig. 6 . Altogether, our results revealed that MPSSS may serve as a potential anti-cancer agent though reversing T cell inhibition by MDSCs (Fig. 6 ). 
